The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001341:Autonomic Nervous System / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D046508:Culture Techniques; D003913:Dextroamphetamine / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006977:Hypertension, Renal / Q000188:drug therapy; D007275:Injections, Intravenous; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009928:Organ Specificity / Q000187:drug effects; D011726:Pyridinium Compounds / Q000494:pharmacology; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology
D000959:Antihypertensive Agents; D011726:Pyridinium Compounds; D000804:Angiotensin II; D009538:Nicotine; D003913:Dextroamphetamine; D009638:Norepinephrine; D014439:Tyramine